Literature DB >> 12578291

Rhinitis in 10-year-old children and early life risk factors for its development.

S H Arshad1, R J Kurukulaaratchy, M Fenn, L Waterhouse, S Matthews.   

Abstract

AIM: To study the prevalence, characteristics of and risk factors for childhood rhinitis.
METHODS: In a whole population birth cohort study (n = 1,456) the prevalence and characteristics of rhinitis among 10-y-old children were examined. At this age 1373 children (94%) completed standardized questionnaires, 1,043 (72%) skin-prick testing, 953 (65%) serum inhalant immunoglobulin E antibody screening and 784 (54%) methacholine bronchial challenges.
RESULTS: At the age of 10 y the prevalence of hayfever ever was 18.6% and current nasal symptoms (rhinitis) 22.6%. Rhinitis at 10 y was largely seasonal and associated with low morbidity, although 62.7% of cases required pharmacological treatment. Atopy (positive skin test) and other allergic states were associated with rhinitis (p < 0.001). Wheeze or diagnosed asthma was higher with coexistent rhinitis. Among wheezing children physician-diagnosed asthma (p < 0.024) and inhaled corticosteroid use (p < 0.001) were greater with the presence of rhinitis. Significant bronchial hyperresponsiveness (methacholine concentration giving a 20% fall in forced expiratory volume in I s <4.0 mg ml(-1)) was greater if rhinitis was present even when the child did not wheeze (p < 0.001). Risk factor analysis for rhinitis identified the independent significance for atopy (p < 0.001) and eczema (p = 0.009) at the age of 4 y plus paternal rhinitis (p < 0.001), maternal rhinitis (p = 0.033) and maternal food allergy (p = 0.016).
CONCLUSION: Rhinitis is common at the age of 10 y, with strong associations with atopy, wheezing, asthma and bronchial hyperresponsiveness. An inherited predisposition towards atopy appears to predominate over environment in the aetiology of this state.

Entities:  

Mesh:

Year:  2002        PMID: 12578291     DOI: 10.1111/j.1651-2227.2002.tb02830.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

Review 1.  Allergic rhinoconjunctivitis in children.

Authors:  Hans de Groot; Paul L P Brand; Wytske F Fokkens; Marjolein Y Berger
Journal:  BMJ       Date:  2007-11-10

2.  Cohort Profile: The Isle Of Wight Whole Population Birth Cohort (IOWBC).

Authors:  S Hasan Arshad; John W Holloway; Wilfried Karmaus; Hongmei Zhang; Susan Ewart; Linda Mansfield; Sharon Matthews; Claire Hodgekiss; Graham Roberts; Ramesh Kurukulaaratchy
Journal:  Int J Epidemiol       Date:  2018-08-01       Impact factor: 7.196

3.  Validating childhood symptoms with physician-diagnosed allergic rhinitis.

Authors:  Haejin Kim; Linda Levin; Grace K LeMasters; Manuel Villareal; Sherry Evans; James E Lockey; Gurjit K Khurana Hershey; David I Bernstein
Journal:  Ann Allergy Asthma Immunol       Date:  2012-02-28       Impact factor: 6.347

4.  Long-term effects of breastfeeding, maternal smoking during pregnancy, and recurrent lower respiratory tract infections on asthma in children.

Authors:  Wilfried Karmaus; Alina L Dobai; Ikechukwu Ogbuanu; Syed Hasan Arshard; Sharon Matthews; Susan Ewart
Journal:  J Asthma       Date:  2008-10       Impact factor: 2.515

5.  Patterns of GATA3 and IL13 gene polymorphisms associated with childhood rhinitis and atopy in a birth cohort.

Authors:  Marianne Huebner; Dong-Yun Kim; Susan Ewart; Wilfried Karmaus; Alireza Sadeghnejad; Syed H Arshad
Journal:  J Allergy Clin Immunol       Date:  2007-11-26       Impact factor: 10.793

6.  Clinically diagnosed childhood asthma and follow-up of symptoms in a Swedish case control study.

Authors:  Eduardo Roel; Ashild Faresjö; Olle Zetterström; Erik Trell; Tomas Faresjö
Journal:  BMC Fam Pract       Date:  2005-04-21       Impact factor: 2.497

7.  Early childhood risk factors for rhinoconjunctivitis in adolescence: a prospective birth cohort study.

Authors:  Elisabeth Soegaard Christiansen; Henrik Fomsgaard Kjaer; Esben Eller; Carsten Bindslev-Jensen; Arne Høst; Charlotte Gotthard Mortz; Susanne Halken
Journal:  Clin Transl Allergy       Date:  2017-04-03       Impact factor: 5.871

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.